Release Date: 04/08/15 15:16 Summary: Restated Financial Statements 30 June 2014 Price Sensitive: No Download Document 6.64MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%